Bio-Techne Investor Relations Material
Latest events
Q4 2025
Bio-Techne
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Bio-Techne Corporation
Access all reports
Bio-Techne Corporation develops, manufactures, and sells life sciences research and clinical diagnostic products. The company’s portfolio includes proteins, antibodies, reagents, and diagnostic instruments supporting academic research, biopharmaceutical production, and clinical testing. Bio-Techne serves scientists and healthcare providers globally. The company is headquartered in Minneapolis, Minnesota, and its shares are listed on the NASDAQ.
Latest articles
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
Ticker symbol
TECH
Country
🇺🇸 United States